Literature DB >> 23824793

CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Nicholas Francella1, Sarah E Gwyn, Yanjie Yi, Bing Li, Peng Xiao, Sarah T C Elliott, Alexandra M Ortiz, James A Hoxie, Mirko Paiardini, Guido Silvestri, Cynthia A Derdeyn, Ronald G Collman.   

Abstract

CD4(+) T cells rather than macrophages are the principal cells infected by human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) in vivo. Macrophage tropism has been linked to the ability to enter cells through CCR5 in conjunction with limiting CD4 levels, which are much lower on macrophages than on T cells. We recently reported that rhesus macaques (RM) experimentally depleted of CD4(+) T cells before SIV infection exhibit extensive macrophage infection as well as high chronic viral loads and rapid progression to AIDS. Here we show that early-time-point and control Envs were strictly CD4 dependent but that, by day 42 postinfection, plasma virus of CD4(+) T cell-depleted RM was dominated by Envs that mediate efficient infection using RM CCR5 independently of CD4. Early-time-point and control RM Envs were resistant to neutralization by SIV-positive (SIV(+)) plasma but became sensitive if preincubated with sCD4. In contrast, CD4-independent Envs were highly sensitive to SIV(+) plasma neutralization. However, plasma from SIV-infected CD4(+) T cell-depleted animals lacked this CD4-inducible neutralizing activity and failed to neutralize any Envs regardless of sCD4 pre-exposure status. Enhanced sensitivity of CD4-independent Envs from day 42 CD4(+) T cell-depleted RM was also seen with monoclonal antibodies that target both known CD4-inducible and other Env epitopes. CD4 independence and neutralization sensitivity were both conferred by Env amino acid changes E84K and D470N that arose independently in multiple animals, with the latter introducing a potential N-linked glycosylation site within a predicted CD4-binding pocket of gp120. Thus, the absence of CD4 T cells results in failure to produce antibodies that neutralize CD4-independent Envs and CD4-pretriggered control Envs. In the absence of this constraint and with a relative paucity of CD4(+) target cells, widespread macrophage infection occurs in vivo accompanied by emergence of variants carrying structural changes that enable entry independently of CD4.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824793      PMCID: PMC3754144          DOI: 10.1128/JVI.01254-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

Authors:  Chih-chin Huang; Miro Venturi; Shahzad Majeed; Michael J Moore; Sanjay Phogat; Mei-Yun Zhang; Dimiter S Dimitrov; Wayne A Hendrickson; James Robinson; Joseph Sodroski; Richard Wyatt; Hyeryun Choe; Michael Farzan; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

2.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

Authors:  S Koenig; H E Gendelman; J M Orenstein; M C Dal Canto; G H Pezeshkpour; M Yungbluth; F Janotta; A Aksamit; M A Martin; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

3.  Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor.

Authors:  R Collman; B Godfrey; J Cutilli; A Rhodes; N F Hassan; R Sweet; S D Douglas; H Friedman; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.

Authors:  Tatsuhiko Igarashi; Hiromi Imamichi; Charles R Brown; Vanessa M Hirsch; Malcolm A Martin
Journal:  J Leukoc Biol       Date:  2003-11       Impact factor: 4.962

5.  Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.

Authors:  Paul J Peters; Jayanta Bhattacharya; Samantha Hibbitts; Matthias T Dittmar; Graham Simmons; Jeanne Bell; Peter Simmonds; Paul R Clapham
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Authors:  Vanessa M Hirsch; Sampa Santra; Simoy Goldstein; Ronald Plishka; Alicia Buckler-White; Aruna Seth; Ilnour Ourmanov; Charles R Brown; Ronald Engle; David Montefiori; Jennifer Glowczwskie; Kevin Kunstman; Steven Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4.

Authors:  Elena Ryzhova; J Charles Whitbeck; Gabriela Canziani; Susan V Westmoreland; Gary H Cohen; Roselyn J Eisenberg; Andrew Lackner; Francisco González-Scarano
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.

Authors:  Houman Dehghani; Bridget A Puffer; Robert W Doms; Vanessa M Hirsch
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus.

Authors:  Jörn E Schmitz; Marcelo J Kuroda; Sampa Santra; Meredith A Simon; Michelle A Lifton; Wenyu Lin; Rajinder Khunkhun; Michael Piatak; Jeffrey D Lifson; Gudrun Grosschupff; Rebecca S Gelman; Paul Racz; Klara Tenner-Racz; Keith A Mansfield; Norman L Letvin; David C Montefiori; Keith A Reimann
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Viral determinants of HIV-1 macrophage tropism.

Authors:  Christopher J A Duncan; Quentin J Sattentau
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.048

View more
  9 in total

1.  Dualtropic CXCR6/CCR5 Simian Immunodeficiency Virus (SIV) Infection of Sooty Mangabey Primary Lymphocytes: Distinct Coreceptor Use in Natural versus Pathogenic Hosts of SIV.

Authors:  Sarah T C Elliott; Katherine S Wetzel; Nicholas Francella; Steven Bryan; Dino C Romero; Nadeene E Riddick; Farida Shaheen; Thomas Vanderford; Cynthia A Derdeyn; Guido Silvestri; Mirko Paiardini; Ronald G Collman
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

2.  Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.

Authors:  Samantha Burton; Lori M Spicer; Tysheena P Charles; Sailaja Gangadhara; Pradeep B J Reddy; Tiffany M Styles; Vijayakumar Velu; Sudhir Pai Kasturi; Traci Legere; Eric Hunter; Bali Pulendran; Rama Amara; Peter Hraber; Cynthia A Derdeyn
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 3.  HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.

Authors:  Paul R Gorry; Nicholas Francella; Sharon R Lewin; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2013-10-24       Impact factor: 4.962

4.  Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.

Authors:  Katie M Kilgore; Megan K Murphy; Samantha L Burton; Katherine S Wetzel; S Abigail Smith; Peng Xiao; Sharmila Reddy; Nicholas Francella; Donald L Sodora; Guido Silvestri; Kelly S Cole; Francois Villinger; James E Robinson; Bali Pulendran; Eric Hunter; Ronald G Collman; Rama R Amara; Cynthia A Derdeyn
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

5.  Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Authors:  Po-Jen Yen; Alon Herschhorn; Hillel Haim; Ignacio Salas; Christopher Gu; Joseph Sodroski; Dana Gabuzda
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

6.  Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Authors:  Adrienne E Swanstrom; Beth Haggarty; Andrea P O Jordan; Josephine Romano; George J Leslie; Pyone P Aye; Preston A Marx; Andrew A Lackner; Gregory Q Del Prete; James E Robinson; Michael R Betts; David C Montefiori; Celia C LaBranche; James A Hoxie
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

7.  CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells.

Authors:  Luca Micci; Xavier Alvarez; Robin I Iriele; Alexandra M Ortiz; Emily S Ryan; Colleen S McGary; Claire Deleage; Brigitte B McAtee; Tianyu He; Cristian Apetrei; Kirk Easley; Savita Pahwa; Ronald G Collman; Cynthia A Derdeyn; Miles P Davenport; Jacob D Estes; Guido Silvestri; Andrew A Lackner; Mirko Paiardini
Journal:  PLoS Pathog       Date:  2014-10-30       Impact factor: 6.823

8.  Decreased plasticity of coreceptor use by CD4-independent SIV Envs that emerge in vivo.

Authors:  Nicholas Francella; Sarah T C Elliott; Yanjie Yi; Sarah E Gwyn; Alexandra M Ortiz; Bing Li; Guido Silvestri; Mirko Paiardini; Cynthia A Derdeyn; Ronald G Collman
Journal:  Retrovirology       Date:  2013-11-12       Impact factor: 4.602

9.  Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Claudia R Avalos; Sarah L Price; Ellen R Forsyth; Julia N Pin; Erin N Shirk; Brandon T Bullock; Suzanne E Queen; Ming Li; Dane Gellerup; Shelby L O'Connor; M Christine Zink; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.